Semmler A

ORCID: 0000-0003-2426-5305 · 2 papers in corpus
2025
Therapeutics and clinical risk management ·doi:10.2147/tcrm.s273358

IntroductionUlipristal acetate (UPA, 5 mg) demonstrated efficacy in symptom reduction for patients with symptomatic fibroids. While registration and post-marketing trials assessing UPA identified few hepatic concerns, post-marketing concern…

rct 2025
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.15165

INTRODUCTION: Uterine artery embolization (UAE) is a less-invasive alternative for hysterectomy in therapy-resistant symptomatic adenomyosis. Comparative data are lacking. Our objective is to evaluate the non-inferiority of UAE compared wit…